Aseptic Fill-Finish Contract Manufacturing Market
完整報告名稱與涵蓋範圍
Aseptic Fill-Finish Contract Manufacturing Market Size, Share & Trends Analysis Report, By Service Type (Vial Filling, Prefilled Syringe and Cartridge Filling, Lyophilization and Powder Filling, Device Assembly, Labelling and Packaging, Formulation Development and Analytical Services), By Molecule Type (Biologics and Vaccines, Small-Molecule Injectables, Cell, Gene and Nucleic Acid Therapies, Peptides and Complex Injectables), By Scale (Clinical Supply, Commercial Supply), By End User, By Region, and Segment Forecasts, 2026-2035
報告摘要
The aseptic fill-finish contract manufacturing market covers outsourced sterile drug product manufacturing for injectable medicines, including vial, prefilled syringe and cartridge filling, lyophilization, device assembly and packaging, and associated formulation and analytical services, across biologics, vaccines, small-molecule injectables, advanced therapies and complex peptides. Captive fill-finish operations and the manufacture of drug substance are excluded.
Sterile capacity has become one of the tightest links in the pharmaceutical supply chain as biologics, biosimilars, GLP-1 pens and advanced therapies compete for filling slots, and as regulators enforce revised annex requirements that favour isolator-based lines and contamination control strategies. Originators have responded by acquiring fill-finish networks, reserving capacity years ahead and dual-sourcing, while providers invest in isolator lines, ready-to-use component handling, high-speed syringe and cartridge filling, small-batch flexible suites for rare-disease products and cold-chain capabilities for nucleic acid and cell therapies. Component shortages, sterile-line qualification timelines and workforce constraints limit how fast capacity can respond.
North America and Europe hold most high-end capacity, with South Korea, India and China expanding sterile manufacturing for biosimilars and generics. Competition includes dedicated sterile specialists, integrated CDMOs and pharmaceutical groups offering excess capacity.
The InsightAce study supplies US$ forecasts for all service type, molecule type, scale and end user and regional segments over 2026-2035, segment-level trend analysis, competitive landscape assessment and profiling of the leading companies.
授權報價
| Single User | $4,500 USD |
| Enterprise / Global Site Licence | $9,500 USD |
目錄 Table of Contents
Chapter 1. Methodology and Scope
1.1. Research Methodology
1.2. Research Scope & Assumptions
Chapter 2. Executive Summary
Chapter 3. Global Aseptic Fill-Finish Contract Manufacturing Market Snapshot
Chapter 4. Global Aseptic Fill-Finish Contract Manufacturing Market Variables, Trends & Scope
4.1. Market Segmentation & Scope
4.2. Market Drivers
4.3. Market Challenges
4.4. Emerging Trends
4.5. Investment and Funding Analysis
4.6. Industry Analysis - Porter's Five Forces Analysis
4.7. Competitive Landscape and Market Positioning
4.8. Market Opportunity Analysis
Chapter 5. Market Segmentation 1: By Service Type Estimates & Trend Analysis
5.1. Service Type & Market Share, 2026 & 2035
5.2. Market Size (Value US$ Mn) & Forecasts and Trend Analysis, 2026 to 2035, by Service Type:
5.2.1. Vial Filling
5.2.2. Prefilled Syringe and Cartridge Filling
5.2.3. Lyophilization and Powder Filling
5.2.4. Device Assembly, Labelling and Packaging
5.2.5. Formulation Development and Analytical Services
Chapter 6. Market Segmentation 2: By Molecule Type Estimates & Trend Analysis
6.1. Molecule Type & Market Share, 2026 & 2035
6.2. Market Size (Value US$ Mn) & Forecasts and Trend Analysis, 2026 to 2035, by Molecule Type:
6.2.1. Biologics and Vaccines
6.2.2. Small-Molecule Injectables
6.2.3. Cell, Gene and Nucleic Acid Therapies
6.2.4. Peptides and Complex Injectables
Chapter 7. Market Segmentation 3: By Scale Estimates & Trend Analysis
7.1. Scale & Market Share, 2026 & 2035
7.2. Market Size (Value US$ Mn) & Forecasts and Trend Analysis, 2026 to 2035, by Scale:
7.2.1. Clinical Supply
7.2.2. Commercial Supply
Chapter 8. Market Segmentation 4: By End User Estimates & Trend Analysis
8.1. End User & Market Share, 2026 & 2035
8.2. Market Size (Value US$ Mn) & Forecasts and Trend Analysis, 2026 to 2035, by End User:
8.2.1. Large Pharmaceutical Companies
8.2.2. Biotechnology Companies
8.2.3. Generic and Biosimilar Manufacturers
Chapter 9. Aseptic Fill-Finish Contract Manufacturing Market: Regional Estimates & Trend Analysis
9.1. North America
9.1.1. United States
9.1.2. Canada
9.2. Europe
9.2.1. Germany
9.2.2. United Kingdom
9.2.3. France
9.2.4. Italy
9.2.5. Spain
9.2.6. Rest of Europe
9.3. Asia Pacific
9.3.1. China
9.3.2. Japan
9.3.3. India
9.3.4. South Korea
9.3.5. Australia
9.3.6. Southeast Asia
9.3.7. Rest of Asia Pacific
9.4. Latin America
9.4.1. Brazil
9.4.2. Mexico
9.4.3. Rest of Latin America
9.5. Middle East & Africa
9.5.1. GCC Countries
9.5.2. South Africa
9.5.3. Rest of Middle East & Africa
Chapter 10. Competitive Landscape
10.1. Company Market Positioning Analysis
10.2. Strategic Developments (Partnerships, Expansions, Product Launches, M&A)
Chapter 11. Company Profiles
11.1. Novo Nordisk A/S (Catalent)
11.2. Vetter Pharma International GmbH
11.3. Lonza Group AG
11.4. Thermo Fisher Scientific Inc. (Patheon)
11.5. Recipharm AB
11.6. Samsung Biologics Co., Ltd.
11.7. Fujifilm Diosynth Biotechnologies
11.8. Boehringer Ingelheim International GmbH
11.9. Baxter International Inc. (BioPharma Solutions)
11.10. Aenova Group
11.11. Grand River Aseptic Manufacturing
11.12. Curia Global, Inc.
11.13. Jubilant HollisterStier LLC
11.14. Pfizer CentreOne
11.15. Aurigene Pharmaceutical Services Ltd.
圖表清單 List of Tables & Figures
Table 1. Global Aseptic Fill-Finish Contract Manufacturing Revenue Forecast by Service Type, 2026-2035 (US$ Mn)
Figure 1. Global Aseptic Fill-Finish Contract Manufacturing Market Snapshot, 2026 & 2035
Table 2. Global Aseptic Fill-Finish Contract Manufacturing Revenue Forecast by Molecule Type, 2026-2035 (US$ Mn)
Figure 2. Global Aseptic Fill-Finish Contract Manufacturing Market Share by Molecule Type, 2026 & 2035
Table 3. Global Aseptic Fill-Finish Contract Manufacturing Revenue Forecast by Scale, 2026-2035 (US$ Mn)
Figure 3. Global Aseptic Fill-Finish Capacity Additions by Format and Provider, 2024-2029
Table 4. Global Aseptic Fill-Finish Contract Manufacturing Revenue Forecast by End User, 2026-2035 (US$ Mn)
Figure 4. Isolator Adoption and Revised Annex 1 Compliance Across Contract Filling Lines
Table 5. North America Aseptic Fill-Finish Contract Manufacturing Revenue by Country, 2026-2035 (US$ Mn)
Figure 5. Asia Pacific Aseptic Fill-Finish Contract Manufacturing Growth Opportunity Analysis
Table 6. Europe Aseptic Fill-Finish Contract Manufacturing Revenue by Country, 2026-2035 (US$ Mn)
Figure 6. Prefilled Syringe, Cartridge and Vial Demand Mix by Molecule Type, 2026-2035
Table 7. Asia Pacific Aseptic Fill-Finish Contract Manufacturing Revenue by Country, 2026-2035 (US$ Mn)
Figure 7. Competitive Positioning of Key Aseptic Fill-Finish Contract Manufacturing Market Participants
Table 8. Latin America and Middle East & Africa Aseptic Fill-Finish Contract Manufacturing Revenue Forecast, 2026-2035 (US$ Mn)
提及公司
常見問題
這份報告可以先索取樣本嗎？
可以。建議購買前先申請樣本，提出申請後約 2 個工作天內提供，您可以先確認內容涵蓋範圍是否符合需求。
報告價格如何計算？
報告以美元標價，台幣報價依當日匯率換算並加計 5% 營業稅。不同授權版本（單人／多人／企業全站）價格不同，量子訊息會評估您的使用情境後提供最優惠報價。
下單後多久交付？如何付款？
一般 3–7 個工作天交付，實際依出版商狀況於下單前確認。收到報告確認無誤後開立台幣發票，30 天內電匯付款即可。
量子訊息有限公司為 InsightAce Analytic 在台灣的授權代理，提供報告購買、樣本申請與授權諮詢。電話 +886 2 7751 5192 ・ 聯絡我們